TrianglePUBLICATIONS · 35042071
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2022 Mar
- First author
- Groenendijk A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Groenendijk A
- type
- Author
- name
- van Tinteren H
- type
- Author
- name
- Jiang Y
- type
- Author
- name
- de Krijger RR
- type
- Author
- name
- Vujanic GM
- type
- Author
- name
- Godzinski J
- type
- Author
- name
- Rübe C
- type
- Author
- name
- Schenk JP
- type
- Author
- name
- Morosi C
- type
- Author
- name
- Pritchard-Jones K
- type
- Author
- name
- Al-Saadi R
- type
- Author
- name
- Vaidya SJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Groenendijk A
- type
- Author
- name
- van Tinteren H
- type
- Author
- name
- Jiang Y
- type
- Author
- name
- de Krijger RR
- type
- Author
- name
- Vujanic GM
- type
- Author
- name
- Godzinski J
- type
- Author
- name
- Rübe C
- type
- Author
- name
- Schenk JP
- type
- Author
- name
- Morosi C
- type
- Author
- name
- Pritchard-Jones K
- type
- Author
- name
- Al-Saadi R
- type
- Author
- name
- Vaidya SJ
- type
- Author
- bibliography ids
- nci-bib-6dac70c1a79486f16a00f254
- book metadata
- content sha256
- 5611d8b79dc78c5cfe3ac36577e7e157be97658acbad2ed75a39aa0c984b5f37
- document type
- citation
- dois
- 10.1016/j.ejca.2021.12.014
- electronic publication date
- display
- 2022 Jan 15
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35042071
- immutable id
- pubmed:35042071@5611d8b79dc78c5cfe3ac36577e7e157be97658acbad2ed75a39aa0c984b5f37
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- Source null
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 88-97
- volume
- 163
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35042071
- provenance
- batch id
- 3f4d1914d2afe41e9e70
- provider
- NCBI PubMed ESummary
- record sha256
- 6d2b208c39c744446c55d381db0ec3c8796f679f57bffea715c3b7bac727f2f4
- response sha256
- 0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
- retrieved at
- 2026-09-09T23:48:06.522634+00:00
- publication date
- display
- 2022 Mar
- precision
- month
- year
- 2022
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Preserved source evidence · Not medical advice